asbestos lawyers - Worthington & Caron, PC

Over $2.5 billion

obtained for mesothelioma patients & families

In the News

301 results found. Viewing page 6 of 61. Go to page 1 2 3 4 5 6 7  . . . 57 58 59 60 61   Next
Jul 8 2022

EPA Proposes Expanding Asbestos Risk Assessment

This past April, the Environmental Protection Agency proposed banning the use, manufacture and import of the most pervasive type of asbestos, chrysotile. Although advocates continued to demand a complete ban of all forms of asbestos, the EPA’s ...

Continue Reading...
Jun 23 2022

Should Workplace Asbestos Exposure be Less Protected than the General Population?

When it comes to asbestos cancer risks, should workers be treated differently than the general population? That is the question posed in a recent blog opinion published by the Environmental Defense Fund. Unfortunately, the EPA ’s recently ...

Continue Reading...
Jun 17 2022

Europe's Renovation Wave Poses Risk to Construction Workers

As Europe aims to reach climate neutrality by 2050, it is grappling with the risk of exposing construction workers to asbestos. Although admirable, Europe’s goal to renovate 220 million buildings in order to “slash energy emissions, ...

Continue Reading...
Jun 10 2022

Carbon Nanotubes Mimic Asbestos Fibers

Nanotechnology has revolutionized multiple industries in its broad application across medical, industrial, consumer and technological sectors. However, certain types of nanotechnology, such as carbon nanotubes (CNTs), have been shown to closely ...

Continue Reading...
Jun 9 2022

Galinpepimut-S in the Treatment of Late-Stage Pleural Mesothelioma

SELLAS Life Sciences Group (SELLAS) has announced promising results of a Phase 1 clinical trial of the combination of immunotherapy agents Galinpepimut-S (GPS) and nivolumab for patients with WT1 positive malignant pleural mesothelioma. GPS is an ...

Continue Reading...
301 results found. Viewing page 6 of 61. Go to page 1 2 3 4 5 6 7  . . . 57 58 59 60 61   Next

Get Empowered

We put your medical and personal needs first and provide compassionate representation.

Please enter the captcha above: